1. American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care 22(Suppl 1):S32-S41, 1999.
2. Grossman JA. Successful management of type 2 diabetes. Are the benefits worth the costs? Pract Diabetology 12-22, June 1999.
3. Palmer AJ, Weiss C, Sendi PP, Neeser K, Brandt A, Singh G, Wenzel H, Spinas GA. The cost-effectiveness of different management strategies for type 1 diabetes: a Swiss perspective. Diabetologia 43:13-26, 2000.
4. Marrero, David: Current effectiveness of diabetes health care in the U.S.: How far from the ideal?. Diabetes Reviews 2:292-309, 1994.
5. Peters AL, Davidson MB: Quality of Outpatient Care Provided to Diabetic Patients: A health maintenance organization experience. Diabetes Care 6:601-606, 1996.
6. Davidson MB: Diabetes Care in Health Maintenance Organization and Fee-For-Service Settings. Dis Manage Health Outcomes 2:189-197, 1997.
7. Suh DC. Disease management program for diabetes mellitus: principles and components. Endocrinologist 9:379-387, 1999.)
8. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in US adults. The third national health and nutrition examination survey. Diabetes Care 1998;21:518-524.
9. Rubin RJ, Altman WM, Mendelson DN: Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 78:809A-809F, 1994.
10. The Diabetes Control and Complications Trial Research Group: The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. N Eng J Med 329:977-986, 1993.
11. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:839-855, 1998
12. Davidson MB. Evidence-based performance and outcomes measures for diabetes care. Dis Manage Health Outcomes 2:124-133, 1997.
13. American Diabetes Association: Diabetes Facts and Figures. Available at: http://www.diabetes.org/ada/c20f.asp. Accessed September 1, 2000.
14. Ellwood PM, Lindberg GD. Managed Care. A work in progress. JAMA 276:1083-1086, 1996.
15. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM. A diabetes report card for the US: quality of care in the 1990s. Ann Int Med 13:565-74, 2002.
16. Harmel AP, Ryan D, Thompson R. Glycohemoglobin assessment program: glycated hemoglobin and epidemiologic variables in patients with type 2 diabetes. Endocr Pract 2002;8:184-90.
17. Thomas JL. Pharmacy Benefit Report: Trends and Forecasts. East Hanover, NJ. Novartis, 1998.
18. Diabetes Control and Complications Trial Research Group. Resource utilization and costs of care in the Diabetes Control and Complications Trial. Diabetes Care 18:1468-1478, 1995.
19. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Epidemiology of diabetes interventions and complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 22:99-111, 1999.
20. The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287:2563-9, 2002
21. DQIP. Diabetes quality improvement project, initial measure set. August 14, 1998: http://www.diabetes.org/dqip.asp.
22. Rickheim PL. Weaver TW, Flader JL, Kendall DM. Assessment of group versus individual diabetes education. Diabetes Care 25:269-274, 2002.
23. Brown SA: Studies of educational interventions and outcomes in diabetic adults: a meta-analysis revisited. Patient Educ Counsel 16:189-215, 1990.
24. Norris SL, Engelgau MM, Narayan KMV: Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 24:561-587, 2001.
25. Wagner EH, Grothaus LC, Sandhu N, Galvin MS, McGregor M, Artz K, Coleman E. Chronic care clinics for diabetes in primary care: a system-wide randomized trial. Diabetes Care 24:695-700, 2001.
26. Pastors JG, Warshaw H, Daly A, Franz M, Kulkarni K. The evidence for the effectiveness of medical nutrition therapy in diabetes management. Diabetes Care 25:608-613, 2002.
27. Ammerman AS, Lindquist CH, Lohr KN, Hersey J. The efficacy of behavioral interventions to modify dietary fat and fruit and vegetable intake: a review of the evidence. Preventive Medicine. 35:25-41, 2002
28. Mensing C, Boucher J, Cypress M, Weinger K, Mulcahy K, Barta P, Hosey G, Kopher W, Lasichak A, Lamb B, Mangan M, Norman J, Tanja J, Yauk L, Wisdom K, Adams C. Standards and Review Criteria National Standards for Diabetes Self-Management Education Diabetes Care 25:S140-S147, 2002
29. NDEP
30. McFarlane SI et al. Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care 2002;25:718-723.
31. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA 288:1775-1779, 2002.
32. Stroebel RJ. Scheitel SM. Fitz JS. Herman RA. Naessens JM. Scott CG. Zill DA. Muller L. A randomized trial of three diabetes registry implementation strategies in a community internal medicine practice. Joint Commission Journal on Quality Improvement. 28:441-50, 2002.
33. Clark CM Jr. Snyder JW. Meek RL. Stutz LM. Parkin CG. A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction. Diabetes Care. 24:1079-86, 2001.
34. Berg GD. Wadhwa S. Diabetes disease management in a community-based setting. Managed Care. 11:42, 45-50, 2002.
35. Wagner EH. Sandhu N. Newton KM. McCulloch DK. Ramsey SD. Grothaus LC. Effect of improved glycemic control on health care costs and utilization. JAMA. 285:182-9, 2001.
36. Sidorov J, Shull R, Tomcavage J, Girolami S, Lawton N, Harris R. Does diabetes disease management save money and improve outcomes? Diabetes Care 25:684-689, 2002.
37. Rubin RJ, Dietrich KA, Hawk AD. Clinical and economic impact of implementing a comprehensive diabetes management program in managed care. J Clin Endo Metab 1998;83:2635-2642.
38. Domurat ES. Diabetes managed care and clinical outcomes: The Harbor City, California Kaiser Permanente Diabetes Care System. Am J Manag Care 1999;5:1299-1307.
39. Steffens B. Cost-effective management of type 2 diabetes: providing quality care in a cost-constrained environment. Amer J Man Care 6(Supp):S697-S703, 2000.
40. Davidson MB, Karlan VJ, Hair TL. Effect of a pharmacist-managed diabetes care program in a free medical clinic. Am J Med Qual 15:137-42, 2000.
41. Philis-Tsimikas A, Walker C. Improved care for diabetes in underserved populations. J Ambulatory Care Management 24:39-43, 2001
42. Wagner EH. Quality improvement in chronic illness care: a collaborative approach. Jt Comm J Qual Improv 27:63-80, 2001.
43. Ziemer DC, Goldschmid M, Musey VC, Domin WS, Thule PM, Gallina DL, Phillips LS: Diabetes in urban African Americans, III. Management of type II diabetes in a municipal hospital setting. Am J Med 101:25-33, 1996.
44. Cook CB, Ziemer DC, El-Kebbi I, Gallina DL, Dunbar VG, Ernst KL, Phillips LS: Diabetes in urban African Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes. Diabetes Care 22:1494-1500.
45. Bailey JE. Womeodu RJ. Wan JY. Van Brunt DL. Somes GW. Improvements in diabetes management and outcomes in a Medicaid managed care system. Tennessee Medicine. 94:425-30, 2001.
46. American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 21:296-309, 1998
47. Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 20:1396-1402, 1997.
48. Ossorio RC, Peters AL, Chen LS, Bamford S, Deraco MR, Wald BG. Development of a diabetes registry in an IPA setting-outpatient and inpatient applications. Diabetes 48 (Suppl 1):A419, 1999.
49. Aro S, Kangas T, Reunanen A, Salinto M, Koivisto V. Hospital use among diabetic patients and the general population. Diabetes Care 17:1320-1329, 1994.
50. Queale WS, Seidler AJ, Bracati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Int Med 157:545-52, 1997
51. Pulsinelli WA, Levy DF, Sigsbee B, Scherer P, Plum F. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med 74:540-43, 1983.
52. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycemia an independent predictor of poor outcome after acute stroke? Results of a longterm follow-up study. Brit Med J 314:1303-1306, 1997.
53. Pomposelli JJ, Baxter JK, Babineau TJ, Pomfret EA, Driscoll DF, Forse RA, Bistrian BR. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. J Enteral Parenteral Nutr 12:628-52, 1998.
54. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 22:1408-14, 1999.
55. Levatan C. Controlling hyperglycemia in the hospital: a matter of life and death. Clinical Diabetes 18:17-24, 2000.
56. Malmberg K, Ryden L, Efendic S, Herlitz J. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetes patients with acute myocardial infartcion (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol 26:57-65, 1995.
57. Kalin MF, Tranbaugh RF, Salas J, Zumoff B. Intensive intervention by an endocrinologist-directed diabetes team diminishes excess mortality in patients with diabetes who undergo coronary artery bypass graft. Diabetes 47(Suppl 1):A87, 1998
58. Furnary AP, Zerr KJ, Grunkemeir GL, Starr. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67:352-62, 1999
59. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 63:356-61, 1997.
60. van den Berghe G. Wouters P. Weekers F. Verwaest C. Bruyninckx F. Schetz M. Vlasselaers D. Ferdinande P. Lauwers P. Bouillon R. Intensive insulin therapy in the surgical intensive care unit. New England Journal of Medicine. 345:1359-67, 2001
61. Levetan CS, Passaro MD, Jablonski KA, Ratner RE. Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care 11:1790-5, 1999.
62. Koproski J, Pretto Z, Poetsky L. Effects of an intervention by a diabetes team in hospitalized patients with diabetes. Diabetes Care 20:1553-1555, 1997.
63. Naylor MD, Brooten D, Campbell R, Jacobsen, Mezey MD, Pauly MV, Schwartz JS. Comprehensive discharge planning and home follow-up of hospitalized elders. JAMA 281:613-620, 1999.
64. Mayfield JA, Deb P, Whitecotton L. Work disability and diabetes. Diabetes Care 22:1105-1109, 1999
65. Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus. JAMA 280:1490-1496, 1998.
66. Goldberg RB. Cardiovascular disease in diabetic patients. Med Clin North America 84:81-93, 2000.
67. Herman WH, Alexander CM, Cook JR, Boccuzzi SJ, Musliner TA, Pedersen TR, Kjekshus J, Pyorala K. Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Diabetes Care 22:1771-1778, 1999.
68. Jonsson B, Cook JR, Pedersen TR. The cost-effectiveness of lipid lowering in patients with diabetes: results from the 4S trial. Diabetologia 42:1293-1301, 1999.
69. Nielsen FS, Rossing P, Gall MA, Skott P, Smidt UM, Parving HH: Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes 43:1108-1113, 1994.
70. Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and the MICRO-HOPE substudy. Lancet 355:253-259, 2000.
71. Sica DA. Bakris GL. Type 2 diabetes: RENAAL and IDNT--the emergence of new treatment options. Journal of Clinical Hypertension. 4:52-7, 2002
72. Dahlof B. Devereux RB. Kjeldsen SE. Julius S. Beevers G. Faire U. Fyhrquist F. Ibsen H. Kristiansson K. Lederballe-Pedersen O. Lindholm LH. Nieminen MS. Omvik P. Oparil S. Wedel H. The LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 359:995-1003, 2002
73. Gray A, Raikou M, McGuire A, Fenn P, Sevens R, Cull C, Stratton I, Adler A, Holman R, Turner R. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomized controlled trial (UKPDS 41). BMJ 320:1373-1378, 2000.
74. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diab Res Clin Prac 46:183-190, 1999.
75. Koschinsky T. Heinemann L. Sensors for glucose monitoring: technical and clinical aspects. Diabetes/Metabolism Research Reviews. 17:113-23, 2001.
76. Mudaliar S, Henry RR. Combination therapy for type 2 diabetes. Endo Pract 5:208-219, 1999.
77. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 22:345-354, 1999.
78. Knowler WC, Barrett-Connor E, Lowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. NEJM 346:393-403, 2002
79. Buchanan TA. Xiang AH. Peters RK. Kjos SL. Marroquin A. Goico J. Ochoa C. Tan S. Berkowitz K. Hodis HN. Azen SP. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes. 51:2796-803, 2002.
80. Peters AL, Davidson MB. Application of a diabetes managed care program: the feasibility of using nurses and a computer system to provide effective care. Diabetes Care21:1037-1043, 1998.
81. Gabbay RA, Sidorov JE, Harris RI. Results of the Penn State Geisinger diabetes disease management program: one year follow-up of 870 patients. Diabetes 49(Suppl 1):A218, 2000
82. Aubert RE, Herman WH, Waters J, Moore W, Sutton D, Peterson BL, Bailey CM Koplan JP: Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization: a randomized, controlled trial. Ann Intern Med 129:605-612, 1998
83. Blonde L, Guthrie RD, Testa MA, Obrien TW, Zimmerman RS, Sandberg MI, Theodoras SH, Parkes JL, Ginsberg BH. Diabetes management by a team of diabetes nurse educators, endocrinologists and primary care physicians in a managed care environment. Diabetes 48(Suppl 1):A198, 1999.